Healthcare, Pharmaceuticals and Biotech

Kroll helps organizations in the healthcare, pharmaceuticals and biotechnology sectors address complex business challenges related to governance, risk and transparency.

Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships.

Underpinning these dynamics is the uncertainty created by a post-COVID-19 environment. The implications have been far-reaching and will likely impact the entire life science ecosystem. While companies need to be aware of the risks to their organization, Kroll understands the complexity of these challenges and works with clients worldwide to drive progress, navigate new opportunities and manage risk.

Our life sciences specialists bring practical, in-depth experience to healthcare and life sciences companies, including consumer health, medical devices, diagnostics and pharmaceuticals. We help our clients address their most pressing challenges in in the areas of valuation, expert services, investigations, cyber risk, corporate finance, security, restructuring, legal and business solutions, data analytics, due diligence and regulatory compliance.

Kroll recently spoke with intellectual property expert Alexandra Pygall, a partner at Stephenson Harwood LLP, on patent waivers for the COVID-19 vaccines. Watch this short video to learn more about how patent waivers play a role in the global distribution of vaccines and what it can mean for the future of the healthcare and pharmaceutical industries.